JPRN-UMIN000018464已完成未知
Efficacy and safety of DPP-4 inhibitors in patients with chronic kidney disease - DPP-4 inhibitors for CKD
ihon University School of Medicine0 个研究点目标入组 100 人开始时间: 2015年7月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) CKD stage 4, 5, and 5D 2) less than 20 years old and more than 80 years old 3) Subjects who were treated with steroid 4) Liver dysfunction 5) Subjects who had malignant tumor
研究者
相似试验
招募中
不适用
Efficacy and safety of DPP-4 inhibitors in patients with chronic kidney diseaseChronic kidney diseaseJPRN-UMIN000009493ihon University School of Medicine30
已完成
不适用
Efficacy and safety of DPP-4 inhibitor added to insulin for treatment of type 2 diabetesType 2 diabetesJPRN-UMIN000004678Keio University , School of Mecidicine, Department of Internal Medicine50
已完成
不适用
The efficacy and the safety of the DPP4 inhibitor in patients with type 2 diabetes complicated with renal dysfunctiodiabetes mellitusJPRN-UMIN000030172Osaka Saiseikai Noe Hospital400
已完成
不适用
A Study of Safety and Efficacy of DPP-4 inhibitor in the Treatment of type 2 diabetes in KanagawaType 2 diabetesJPRN-UMIN000014382Diabetes Committee, Kanagawa Physicians Association860
已完成
不适用
Clinical study examining effect of DPP-4 inhibitors on postprandial hyperlipidemiaType 2 diabetes mellitusJPRN-UMIN000010177Shimane University Faculty of Medicine30